Postgenomic Approaches and Bioinformatics Tools to Advance the Development of Vaccines against Bacteria of the Burkholderia cepacia Complex.
- Published in:
- Vaccines, 2018, v. 6, n. 2, p. 34, doi. 10.3390/vaccines6020034
- By:
- Publication type:
- Article
Works matching IS 2076393X AND DT 2018 AND VI 6 AND IP 2
Results: 18
1
2
What’s Fair Is Fair: Leveling the Playing Field for Young Scientists.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
3
Clinical Expectations for Better Influenza Virus Vaccines—Perspectives from the Young Investigators’ Point of View.
- Published in:
- Vaccines, 2018, v. 6, n. 2, p. 32, doi. 10.3390/vaccines6020032
- By:
- Publication type:
- Article
4
Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy.
- Published in:
- Vaccines, 2018, v. 6, n. 2, p. 31, doi. 10.3390/vaccines6020031
- By:
- Publication type:
- Article
5
Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment.
- Published in:
- Vaccines, 2018, v. 6, n. 2, p. 30, doi. 10.3390/vaccines6020030
- By:
- Publication type:
- Article
6
Clinical Advances in Viral-Vectored Influenza Vaccines.
- Published in:
- Vaccines, 2018, v. 6, n. 2, p. 29, doi. 10.3390/vaccines6020029
- By:
- Publication type:
- Article
7
Immune History and Influenza Vaccine Effectiveness.
- Published in:
- Vaccines, 2018, v. 6, n. 2, p. 28, doi. 10.3390/vaccines6020028
- By:
- Publication type:
- Article
8
The Potential Role of Fc-Receptor Functions in the Development of a Universal Influenza Vaccine.
- Published in:
- 2018
- By:
- Publication type:
- Other
9
Correction: Vitetta, L.; et al. Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes. Vaccines 2017, 5, 50.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
10
Should UK Pneumococcal Vaccine Eligibility Criteria Include Alcohol Dependency in Areas with High Alcohol-Related Mortality?
- Published in:
- 2018
- By:
- Publication type:
- Letter
11
Development and Regulation of Novel Influenza Virus Vaccines: A United States Young Scientist Perspective.
- Published in:
- 2018
- By:
- Publication type:
- Other
12
“Gnothi Seauton”: Leveraging the Host Response to Improve Influenza Virus Vaccine Efficacy.
- Published in:
- Vaccines, 2018, v. 6, n. 2, p. 23, doi. 10.3390/vaccines6020023
- By:
- Publication type:
- Article
13
Predictors and Barriers to Full Vaccination among Children in Ethiopia.
- Published in:
- Vaccines, 2018, v. 6, n. 2, p. 22, doi. 10.3390/vaccines6020022
- By:
- Publication type:
- Article
14
Linkage of Infection to Adverse Systemic Complications: Periodontal Disease, Toll-Like Receptors, and Other Pattern Recognition Systems.
- Published in:
- Vaccines, 2018, v. 6, n. 2, p. 21, doi. 10.3390/vaccines6020021
- By:
- Publication type:
- Article
15
New Kids on the Block: RNA-Based Influenza Virus Vaccines.
- Published in:
- Vaccines, 2018, v. 6, n. 2, p. 20, doi. 10.3390/vaccines6020020
- By:
- Publication type:
- Article
16
Efforts to Improve the Seasonal Influenza Vaccine.
- Published in:
- Vaccines, 2018, v. 6, n. 2, p. 19, doi. 10.3390/vaccines6020019
- By:
- Publication type:
- Article
17
Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine.
- Published in:
- Vaccines, 2018, v. 6, n. 2, p. 18, doi. 10.3390/vaccines6020018
- By:
- Publication type:
- Article
18
Epidemiological Studies to Support the Development of Next Generation Influenza Vaccines.
- Published in:
- Vaccines, 2018, v. 6, n. 2, p. 17, doi. 10.3390/vaccines6020017
- By:
- Publication type:
- Article